MICROBIX BIOSYSTEMS INC (MBX.CA) Stock Income Statement
TSX:MBX - Toronto Stock Exchange - CA59501P1045 - Common Stock - Currency: CAD
| TTM (2025-3-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.72M | 25.39M | 16.51M | 19.08M | 18.59M | |||
| Cost Of Goods | 9.60M | 10.00M | 9.03M | 7.95M | 7.55M | |||
| Gross Profit | 13.12M | 15.39M | 7.48M | 11.12M | 11.04M | |||
| Operating Expenses | 10.94M | 11.33M | 10.22M | 8.52M | 6.22M | |||
| Research and Development | 2.25M | 2.09M | 2.01M | 1.79M | 1.07M | |||
| Selling, General, and Administrative Expenses | 8.84M | 8.88M | 8.01M | 6.56M | 5.07M | |||
| Operating Income | 2.18M | 4.06M | -2.74M | 2.61M | 4.82M | |||
| Interest Income/Expense | -467.70K | -392.30K | -380.00K | -740.00K | -1.59M | |||
| Non Recurring Items | N/A | N/A | 3.08M | N/A | 0.00 | |||
| Income Before Taxes | 1.72M | 3.67M | -40.00K | 1.87M | 3.23M | |||
| Income Tax | N/A | 150.60K | 0.00 | 80.00K | 0.00 | |||
| Net Income | 1.56M | 3.52M | -40.00K | 1.79M | 3.23M | |||
| EBITDA | 3.87M | 5.68M | -1.58M | 3.65M | 5.64M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.01 | 0.03 | 0.00 | 0.01 | 0.02 | |||
| Non GAAP EPS | N/A | N/A | 0.02 | 0.01 | 0.03 | |||
| Statistics | ||||||||
| Gross Profit Margin | 57.74% | 60.61% | 45.31% | 58.28% | 59.39% | |||
| Profit Margin | 6.89% | 13.86% | -0.24% | 9.38% | 17.37% | |||
| Operating Profit Margin | 9.61% | 16.00% | -16.60% | 13.68% | 25.93% | |||
All data in CAD